Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/EBIT LTM | (650.0x) | 15.9x | 68.5x | 1.9x | (0.4x) | (3.5x) | (0.2x) | (18.9x) | (5.8x) | (11.4x) | (3.6x) | (31.0x) | 1.8x | 1.4x | 1.6x | 1.9x | 1.8x | 2.3x | 5.3x | 11.2x |
Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 25.2 (55.9%) | 36.9 46.3% | 26.3 (28.6%) | 25.3 (4.0%) | 13.4 (46.8%) | 8.1 (39.9%) | 4.1 (49.4%) | 3.1 (24.8%) | 2.4 (23.4%) | 7.3 208.9% | 33.4 359.3% | 79.0 136.6% | 152.1 92.6% | 199.6 31.3% | 193.3 (3.2%) | 191.7 (0.8%) | 273.0 42.4% | 286.9 5.1% | 355.2 23.8% | 472.8 33.1% |
Cost of Goods Sold (COGS) | 4.0 | 8.1 | 4.2 | 4.4 | 6.4 | 3.9 | 3.6 | 0.7 | 0.9 | 5.2 | 22.1 | 59.0 | 89.5 | 125.4 | 122.4 | 116.4 | 173.5 | 189.1 | 239.6 | 328.0 |
% margin | 21.2 84.2% | 28.8 78.1% | 22.1 84.0% | 20.9 82.6% | 7.0 52.4% | 4.2 52.2% | 0.5 11.7% | 2.4 76.7% | 1.4 61.0% | 2.0 28.1% | 11.3 33.7% | 20.0 25.3% | 62.6 41.1% | 74.2 37.2% | 70.9 36.7% | 75.3 39.3% | 99.5 36.4% | 97.8 34.1% | 115.6 32.5% | 144.8 30.6% |
Operating Expenses | 22.1 | 26.7 | 18.8 | 22.7 | 17.6 | 12.0 | 5.8 | 3.3 | 4.2 | 6.5 | 17.7 | 17.7 | 44.5 | 63.4 | 67.6 | 54.9 | 63.7 | 67.0 | 100.1 | 158.5 |
Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative Expenses (SG&A) | 20.8 | 25.3 | 19.0 | 22.7 | 17.6 | 12.0 | 5.8 | 3.3 | 4.2 | 6.5 | 17.7 | 17.7 | 44.5 | 63.4 | 67.6 | 54.9 | 63.7 | 67.0 | 100.1 | 140.4 |
% margin | (0.8) (3.3%) | 2.1 5.8% | 3.3 12.6% | (1.9) (7.3%) | (18.5) (137.3%) | (7.7) (95.8%) | (5.3) (129.8%) | (0.9) (30.9%) | (2.7) (116.4%) | (4.5) (61.9%) | (10.1) (30.4%) | 2.3 2.9% | 18.1 11.9% | 10.8 5.4% | 6.5 3.4% | 20.4 10.7% | 35.8 13.1% | 13.1 4.6% | 15.4 4.3% | (13.6) (2.9%) |
Interest Income | 0.0 | 0.2 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.3 | 5.3 | 5.2 | 4.2 | 0.0 | 0.0 |
Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.6 | 3.3 | 0.5 | 4.5 | 4.0 | 7.6 | 8.6 | 6.3 | 5.3 | 5.2 | 4.2 | 12.7 | 16.8 |
Pre-tax Income | (1.1) | (1.4) | 3.6 | (1.7) | (10.9) | (7.7) | (5.4) | (1.6) | (5.7) | (4.7) | (14.3) | 5.5 | 10.6 | 10.3 | (5.6) | 15.6 | 39.7 | 31.6 | 1.5 | (31.3) |
% effective tax rate | (0.4) 37.4% | (0.3) 22.9% | 1.9 51.4% | (0.2) 11.0% | 3.4 (31.1%) | (0.2) 3.0% | 0.1 (2.2%) | (0.0) 0.8% | 3.3 (57.2%) | 0.4 (8.6%) | 0.4 (2.6%) | (12.5) (228.8%) | 4.1 38.6% | 4.4 42.7% | (1.6) 28.8% | 5.0 31.7% | 8.7 21.8% | 6.9 21.7% | 1.6 106.9% | (4.7) 14.9% |
% margin | (0.6) (2.5%) | (1.1) (2.8%) | 1.8 6.7% | (1.5) (6.0%) | (22.6) (168.1%) | (7.5) (92.3%) | (5.5) (134.7%) | (1.6) (51.3%) | (5.7) (244.4%) | (4.7) (64.2%) | (14.7) (44.0%) | 17.8 22.6% | 6.5 4.3% | 5.9 3.0% | (4.0) (2.1%) | 10.9 5.7% | 31.2 11.4% | 24.7 8.6% | (0.1) (0.0%) | (26.7) (5.6%) |
EPS | (2.53) | (4.44) | 6.46 | (4.66) | (71.47) | (23.62) | (16.57) | (1.52) | (3.67) | (2.13) | (5.58) | 6.33 | 2.94 | 1.58 | (2.11) | 6.40 | 19.92 | 7.94 | (0.03) | (8.48) |
Diluted EPS | (2.52) | (4.44) | 6.27 | (4.66) | (71.47) | (23.62) | (16.57) | (1.52) | (3.67) | (2.13) | (5.58) | 5.40 | 1.61 | 1.58 | (2.11) | 3.09 | 9.80 | 7.84 | (0.03) | (8.48) |
% margin | 4.0 15.8% | 1.5 4.0% | 6.4 24.2% | 1.4 5.7% | (8.6) (64.2%) | (7.5) (92.5%) | (4.7) (116.3%) | (0.7) (22.4%) | (2.5) (105.2%) | (4.0) (55.2%) | (5.4) (16.1%) | 2.3 2.9% | 23.1 15.2% | 25.0 12.5% | 8.9 4.6% | 20.4 10.7% | 51.5 18.9% | 29.5 10.3% | 33.3 9.4% | (13.6) (2.9%) |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of today, Microsoft Corp's last 12-month P/EBIT LTM is (2.2x), based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/EBIT LTM for Live Ventures Incorporated have been 4.1x over the past three years, and 3.8x over the past five years.
As of today, Live Ventures Incorporated's P/EBIT LTM is (2.2x), which is lower than industry median of 14.2x. It indicates that Live Ventures Incorporated's P/EBIT LTM is Good.